BE640639A - - Google Patents

Info

Publication number
BE640639A
BE640639A BE640639A BE640639A BE640639A BE 640639 A BE640639 A BE 640639A BE 640639 A BE640639 A BE 640639A BE 640639 A BE640639 A BE 640639A BE 640639 A BE640639 A BE 640639A
Authority
BE
Belgium
Application number
BE640639A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE640639A publication Critical patent/BE640639A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Paper (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
BE640639A 1962-12-01 1963-11-29 BE640639A (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1414962 1962-12-01

Publications (1)

Publication Number Publication Date
BE640639A true BE640639A (cg-RX-API-DMAC10.html) 1964-05-29

Family

ID=4398397

Family Applications (1)

Application Number Title Priority Date Filing Date
BE640639A BE640639A (cg-RX-API-DMAC10.html) 1962-12-01 1963-11-29

Country Status (3)

Country Link
AT (1) AT258875B (cg-RX-API-DMAC10.html)
BE (1) BE640639A (cg-RX-API-DMAC10.html)
GB (1) GB1072118A (cg-RX-API-DMAC10.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4664848A (en) 1982-12-23 1987-05-12 The Procter & Gamble Company Detergent compositions containing cationic compounds having clay soil removal/anti-redeposition properties
EP2476756A1 (en) 2005-06-15 2012-07-18 Massachusetts Institute of Technology Amine-containing lipids and uses thereof
WO2010053572A2 (en) 2008-11-07 2010-05-14 Massachusetts Institute Of Technology Aminoalcohol lipidoids and uses thereof
ME03327B (me) 2009-12-01 2019-10-20 Translate Bio Inc Stereoidni derivati za isporuku irnk u humanim genetskim oboljenjima
US9193827B2 (en) 2010-08-26 2015-11-24 Massachusetts Institute Of Technology Poly(beta-amino alcohols), their preparation, and uses thereof
EP2691443B1 (en) 2011-03-28 2021-02-17 Massachusetts Institute of Technology Conjugated lipomers and uses thereof
CN103906527B (zh) 2011-06-08 2020-07-10 川斯勒佰尔公司 Mrna递送的脂质纳米颗粒组合物和方法
WO2013185067A1 (en) 2012-06-08 2013-12-12 Shire Human Genetic Therapies, Inc. Nuclease resistant polynucleotides and uses thereof
CA2884870C (en) 2012-08-13 2022-03-29 Massachusetts Institute Of Technology Amine-containing lipidoids and uses thereof
CN105051190A (zh) 2013-03-14 2015-11-11 夏尔人类遗传性治疗公司 信使rna的纯化方法
HUE042640T2 (hu) 2013-03-14 2019-07-29 Translate Bio Inc CFTR-mRNS-készítmények, valamint kapcsolódó eljárások és alkalmazások
US9315472B2 (en) 2013-05-01 2016-04-19 Massachusetts Institute Of Technology 1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
CA2928188A1 (en) 2013-10-22 2015-04-30 Shire Human Genetic Therapies, Inc. Mrna therapy for argininosuccinate synthetase deficiency
AU2014340155B2 (en) 2013-10-22 2018-11-01 Massachusetts Institute Of Technology Lipid formulations for delivery of messenger RNA
EA201992208A1 (ru) 2013-10-22 2020-07-31 Транслейт Био, Инк. ЛЕЧЕНИЕ ФЕНИЛКЕТОНУРИИ С ПРИМЕНЕНИЕМ мРНК
JP6571679B2 (ja) 2014-04-25 2019-09-04 トランスレイト バイオ, インコーポレイテッド メッセンジャーrnaの精製方法
CA3211902A1 (en) 2014-05-30 2015-12-03 Translate Bio, Inc. Biodegradable lipids for delivery of nucleic acids
CA2952824C (en) 2014-06-24 2023-02-21 Shire Human Genetic Therapies, Inc. Stereochemically enriched compositions for delivery of nucleic acids
EP3164379A1 (en) 2014-07-02 2017-05-10 Massachusetts Institute of Technology Polyamine-fatty acid derived lipidoids and uses thereof
MX2019010155A (es) 2017-02-27 2020-12-10 Translate Bio Inc Arnm de cftr optimizado por codón novedoso.
US11173190B2 (en) 2017-05-16 2021-11-16 Translate Bio, Inc. Treatment of cystic fibrosis by delivery of codon-optimized mRNA encoding CFTR
EP3841208A1 (en) 2018-08-24 2021-06-30 Translate Bio, Inc. Methods for purification of messenger rna
WO2020106946A1 (en) 2018-11-21 2020-05-28 Translate Bio, Inc. TREATMENT OF CYSTIC FIBROSIS BY DELIVERY OF NEBULIZED mRNA ENCODING CFTR

Also Published As

Publication number Publication date
AT258875B (de) 1967-12-11
GB1072118A (en) 1967-06-14

Similar Documents

Publication Publication Date Title
BE616548R (cg-RX-API-DMAC10.html)
BE615962A (cg-RX-API-DMAC10.html)
BE633988A (cg-RX-API-DMAC10.html)
BE380301A (cg-RX-API-DMAC10.html)
BE489310A (cg-RX-API-DMAC10.html)
BE538252A (cg-RX-API-DMAC10.html)
BE538831A (cg-RX-API-DMAC10.html)
BE541929A (cg-RX-API-DMAC10.html)
BE553896A (cg-RX-API-DMAC10.html)
BE559145A (cg-RX-API-DMAC10.html)
BE586180A (cg-RX-API-DMAC10.html)
BE592434A (cg-RX-API-DMAC10.html)
BE599783A (cg-RX-API-DMAC10.html)
BE604335A (cg-RX-API-DMAC10.html)
BE608197A (cg-RX-API-DMAC10.html)
BE609543A (cg-RX-API-DMAC10.html)
BE612190A (cg-RX-API-DMAC10.html)
BE612311A (cg-RX-API-DMAC10.html)
BE612464A (cg-RX-API-DMAC10.html)
BE612847A (cg-RX-API-DMAC10.html)
BE612926A (cg-RX-API-DMAC10.html)
BE613108A (cg-RX-API-DMAC10.html)
BE613190A (cg-RX-API-DMAC10.html)
BE613298A (cg-RX-API-DMAC10.html)
BE615804A (cg-RX-API-DMAC10.html)